NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Antares Pharma, Inc. (NASDAQ: ATRS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Halozyme Therapeutics, Inc. (NASDAQ: HALO).
Click
here
to learn more and participate in the action.
On April 13, 2022, Antares announced that it had entered into an agreement to be acquired by Halozyme in a deal valued at approximately $960 million. Pursuant to the merger agreement, Antares stockholders will receive $5.60 in cash for each share of Antares common stock owned. The deal is scheduled to close in the first half of 2022.
Bragar Eagel & Squire is concerned that Antares’ board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Antares’ stockholders.
If you own shares of Antares and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at
[email protected]
or telephone at (646) 860-9157, or by
filling out this contact form
. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit
www.bespc.com
. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.
[email protected]
www.bespc.com
